A new mouse model of junctional epidermolysis bullosa: the LAMB3 628G>A knockin mouse.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Investigative Dermatology

• Publication date

  2015-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/jid.2014.466PMID 25350318
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa

  2011cited by this paper
• A mouse model of generalized non-Herlitz junctional epidermolysis bullosa.

  2010cited by this paper
• Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

  2009cited by this paper
• Correction of laminin-5 deficiency in human epidermal stem cells by transcriptionally targeted lentiviral vectors.

  2008cited by this paper
• The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB.

  2008cited by this paper
• Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.

  2007cited by this paper
• Biological function of laminin-5 and pathogenic impact of its deficiency.

  2007cited by this paper
• Evaluation of prenatal intra-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease

  2006cited by this paper
• Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells

  2006cited by this paper
• Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease

  2004cited by this paper
• Targeted inactivation of murine laminin gamma2-chain gene recapitulates human junctional epidermolysis bullosa.

  2003cited by this paper
• Targeted Disruption of the LAMA3 Gene in Mice Reveals Abnormalities in Survival and Late Stage Differentiation of Epithelial Cells

  1999cited by this paper
• LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels.

  1998cited by this paper
• Compound heterozygosity for an out-of-frame deletion and a splice site mutation in the LAMB3 gene causes nonlethal junctional epidermolysis bullosa.

  1998cited by this paper
• IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa

  1997cited by this paper
• Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa.

  1995cited by this paper

• Peripheral Blood Nascent RNA Sequencing Captures Ancestry-Linked Differential Gene Expression

  2026cites this paper
• Rare diseases of ectoderm: Translating discovery to therapy

  2022cites this paper
• Aberrant splicing as potential modifier of the phenotype of junctional epidermolysis bullosa

  2020cites this paper
• Hereditary bullous diseases: current and innovative models to study the skin blistering disease epidermolysis bullosa

  2020cites this paper
• Laminins

  2019cites this paper
• Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone.

  2018cites this paper
• Laminin: loss-of-function studies

  2017cites this paper
• Chromosome 1 Sequence Analysis of C57BL/6J-Chr1KM Mouse Strain

  2017cites this paper
• Chapter 29 – Laminins

  2016cites this paper
• Progress Towards Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015

  2015cites this paper